Concepedia
Statistics
Publications
14
Citations
815
H-Index
12
Active since
1995
Affiliations
Takeda (Japan)(Current)
Takeda (United States)
University of British Columbia
Nagoya University
BC Cancer Agency
Momoko Ohori is an author at Takeda (Japan) specializing in medicine, molecular biology, and drug discovery.
Top concepts
MedicineBiochemistryPharmacologyDrug DiscoveryChemical BiologyNatural SciencesMolecular BiologyBatteriesEngineeringEnergy Storage
Publications per year
1995–2020
Aneuploidy generates proteotoxic stress and DNA damage concurrently with p53-mediated post-mitotic apoptosis in SAC-impaired cells
Akihiro Ohashi, Momoko Ohori, Kenichi Iwai et al. · Nature Communications · 2015 · 197 citations · Full text
CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor
Tyler Funnell, Shinya Tasaki, Arusha Oloumi et al. · Nature Communications · 2017 · 134 citations · Full text
Polygenic architecture informs potential vulnerability to drug-induced liver injury
Masaru Koido, Eri Kawakami, Junko Fukumura et al. · Nature Medicine · 2020 · 76 citations · Full text
Polygenic Architecture, Systems Biology, Hepatology +8
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
Toshiya Nishi, Shinichi Kondo, Maki Miyamoto et al. · Scientific Reports · 2020 · 75 citations · Full text
Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor
Kenichi Iwai, Tadahiro Nambu, Ryo Dairiki et al. · Science Advances · 2019 · 67 citations · Full text
1–5 of 14